ANDREW CABALLERO-REYNOLDS/AFP via Getty Images Daniel Payne reports on how the health industry and Washington influence and impact each other. He joined STAT in 2025 after covering health care at POLITICO. You can reach Daniel on Signal at danielp.100. Damian Garde is a reporter at large, live and feature journalism, covering the global drug industry…
WASHINGTON — The Trump administration is nearing deals with Eli Lilly and Novo Nordisk to lower the prices of their weight loss drugs and expand access to them, people familiar with the talks told STAT. The companies have been close to a deal for weeks, one lobbyist with knowledge of the negotiations said, echoing others who…
WASHINGTON — The Trump administration is delaying a proposal to crack down on a loophole that allows drugmakers to avoid Medicare price negotiation on some of their products by making minor tweaks. While President Trump pressures drugmakers to charge Americans prices on par with other rich countries, he rarely mentions that Medicare already has started…
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. I’m happy to report that Last Week Tonight with John Oliver did a segment on the MAHA movement that mentions Sarah Todd’s story, Why…
WASHINGTON — President Trump may aggressively negotiate lower drug prices in Medicare using a program that Democrats created and Trump rarely mentions in public. Since his first term, Trump has demanded that drugmakers charge Americans lower prices for pharmaceuticals, on par with those available in other wealthy countries, a policy often referred to as most-favored…